918
Views
20
CrossRef citations to date
0
Altmetric
Research Article

Identifying an optimal treatment for schizophrenia: A 2-year randomized controlled trial comparing integrated care to a high-quality routine treatment

, , , , &
Pages 118-127 | Received 26 Apr 2010, Accepted 04 Jan 2011, Published online: 08 Feb 2011

References

  • Essock SM, Drake RE, Frank RG, McGuire TG. Randomized controlled trials in evidence-based mental health care: getting the right answer to the right question. Schiz Bull 2003;29:115–23.
  • Gilbody S, Wahlbeck K, Adams C. Randomized controlled trials in schizophrenia: a critical perspective on the literature. Acta Psychiatr Scand 2003;105:243–51.
  • Lehman AF, Lieberman JA, Dixon LB, McGlashan TH, Miller AL, Perkins DO, . American Psychiatric Association; Steering Committee on Practice Guidelines Practice guideline for the treatment of patients with schizophrenia second edition. Am J Psychiatry 2004;161 (Suppl):1–56.
  • National Institute for Clinical Excellence. Schizophrenia: Core interventions in the treatment and management of schizophrenia in primary and secondary care. London: NICE, 2004 Clinical Guideline 1.
  • Lehman AF, Steinwachs DM. Patterns of usual care for schizophrenia. Initial results from the Schizophrenia Patient Outcomes Research Team PORT client survey. Schizo Bull 1998;24:11–20.
  • Falloon IRH, Optimal Treatment Project Collaborators. Optimal treatment for psychosis in an International Multisite Demonstration Project. Psychiatr Serv 1999;50:615–18.
  • Turkington D, Kingdon D, Weiden PJ. Cognitive behavioural therapy for schizophrenia. Am J Psychiatry 2006;163: 365–73.
  • Turkington D, Kingdon D, Chadwick P. Cognitive behavioural therapy for schizophrenia: filling the therapeutic vacuum. Br J Psychiatry 2003;183:98–9.
  • Rathod S, Kingdon D, Smith P, Turkington D. Insight into schizophrenia: the effects of cognitive behaviour therapy on the components of insight and association with sociodemographics-data on a previously published randomized controlled trial. Schizophr Res 2005;74:211–19.
  • Turkingdon D, Kingdon D, Turner T. Effectiveness of a brief cognitive behaviour therapy intervention in the treatment of schizophrenia. Br J Psychiatry 2002;180:523–7.
  • Wykes T, Steel C, Everitt B, Tarrier N. Cognitive behavior therapy for schizophrenia: effect sizes, clinical models, and methodological rigor. Schizophr Bull 2008; 34(3):523–37.
  • Jones C, Cormac I, Silveira da Mota, Neto JI, Campbell C. Cognitive behaviour therapy for schizophrenia. Cochrane Database Syst Rev 2004;4:Art. No. CD000524. DOI: 10.1002/14651858.CD000524.pub2.
  • Falloon IRH, Optimal Treatment Project Collaborators. Integrated mental health care – a guidebook for consumers. Perugia: ARIETE, Optimal Treatment Project; 1997.
  • Falloon IRH, Graham-Hole V, Fadden G . Integrated Mental Health Care: A programme of training in clinical management of mental disorders using effective efficient intervention strategies within a multidisciplinary team. Perugia: ARIETE, Optimal Treatment Project; 1996.
  • Falloon IRH, Mizuno M, Murakami M, Roncone R, Unoka Z, Harangozo J, . Structured assessment of current mental state in clinical practice: An international study of the reliability and validity of the Current Psychiatric State Interview CPS-50. Acta Psychiatr Scand 2005;111:44–50.
  • Guy W. ECDEU Assessment Manual for Psychopharmacology. Washington, DC: US Department of Health Education and Welfare; 1976.
  • Rosser RM, Kind P. A scale of valuations of states of illness: is there a social consensus? Int J Epidemiol 1997; 7:347–58.
  • Falloon IRH. Family management of schizophrenia: clinical social family and economic benefits. Baltimore, MD: Johns Hopkins University Press Monograph; 1985.
  • Phelan M, Slade M, Thornicraft G, Dunn G, Holloway F, Wykes T, . The Camberwell assessment of needs: the validity and reliability of an instrument to assess the needs of people with severe mental illness. Br J Psychiatry 1995; 167:589–95.
  • Heinrichs DW, Hanlon TE, Carpenter WT. The quality of life scale: an instrument for rating the schizophrenic deficit syndrome. Schizophr Bull 1984;10:388–98.
  • Rosenthal R. Parametric measures of effect size. Cooper HM, Hedges LV. The handbook of research synthesis. New York: Russell Sage Foundation; 1994. 236–8.
  • Thornicroft G, Tansella M. Components of a modern mental health service: a pragmatic balance of community and hospital care: overview of systematic evidence. Br J Psychiatry 2004;185:283–90.
  • Leichsenring F. Randomized controlled versus naturalistic studies: a new research agenda. Bull Menninger Clin 2004;68 (2):137–51.
  • Kerwin R. Connecting patient needs with treatment Management. Acta Psychiatr Scand 2009;119(438):32–8.
  • Marshall M, Gray A, Lockwood A, Green R. Case management for people with severe mental disorders. Cochrane Database Syst Rev 1998;2:Art. No. CD000050. DOI: 10.1002/14651858.CD000050.
  • Phillips SD, Burns BJ, Edgar ER, Mueser KT, Linkins KW, Rosenheck RA, . Moving assertive community treatment into standard practice. Psychiatr Serv 2001; 52(6):771–9.
  • Hogarty GE, Anderson CM, Reiss DJ, Sander J, Kornblith SJ, Greenwald, DP, . Family psycho-education social skills training and maintenance chemotherapy in the aftercare treatment of schizophrenia: I. One-year effects of a controlled study on relapse and expressed emotion. Arch Gen Psychiatry 1986;43:633–42.
  • Hogarty GE, Anderson CM, Reiss DJ, Kornblith SJ, Greenwald DP, Ulrich RF, . Family psychoeducation social skills training and maintenance chemotherapy in the aftercare of schizophrenia. II two-year effects of a controlled study on relapse and adjustment. Arch Gen Psychiatry 1991;48:340–7.
  • Hogarty GE, Kornblith SJ, Greenwald D, DiBarry AL, Cooley S, Ulrich RF, . Three-year trials of personal therapy among schizophrenic patients living with or independent of family. I: description of study and effects on relapse rates. Am J Psychiatry 1997;154:1504–13.
  • Hogarty GE, Greenwald D, Ulrich RF, Kornblith SJ, DiBarry AL, Cooley S, . Three-year trials of personal therapy among schizophrenic patients living with or independent of family. II: Effects on adjustment of patients. Am J Psychiatry 1997;154:1514–24.
  • Falloon IRH. Family interventions of mental disorders: efficacy and effectiveness. World Psychiatry 2003;2:20–8.
  • Schooler NR, Keith SJ, Severe JB, Matthews SM, Bellack AS, Glick ID, . Relapse and rehospitalization during maintenance treatment of schizophrenia. The effects of dose reduction and family treatment. Arch Gen Psychiatry 1997;54:453–63.
  • Mueser KT, Torrey WC, Lynde D. Implementing evidence-based practices for people with severe mental illness. Behav Mod 2003;27:387–411.
  • Falloon IRH, Montero I, Sungur M, Mastroeni A, Malm U, Economou M, . Implementation of evidence-based treatment for schizophrenic disorders: two-year outcome of an international field trial of optimal treatment. World Psychiatry 2004;3:104–9.
  • Malm U, Ivarsson B, Allebeck P, Falloon IR. Integrated care in schizophrenia: a 2-year randomized controlled study of two community-based treatment programs. Acta Psychiatr Scand 2003;107:415–23.
  • Falloon IRH, Roncone R, Giosue P, . The integration of innovative biomedical and psychosocial strategies into clinical practice. Kashima H, Falloon IRH, Mizuno M, Asai M. Comprehensive treatment of schizophrenia. Berlin: Springer; 2002. 146–61.
  • Lieberman RP, Kopelowicz A. Recovery from schizophrenia: a concept in search of research. Psychiatric Serv 2005;56: 735–42.
  • Lieberman JA, Stroup TS, McEvoy JP, Swartz MS, Rosenheck RA, Perkins DO, . Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) Investigators. Effectiveness of antipsychotic drugs in patients with chronic schizophrenia. New Engl J Med 2005;353(12): 1209–23.
  • Jablensky A. Epidemiology of schizophrenia: the global burden of disease and disability. Eur Arch Psychiatry Clin Neurosci 2000;250:274–85.
  • Wright J, Turkington D, Kingdon DG, Basko MR. Cognitive behaviour therapy for severe mental illness: an illustrated guide. Wahington, DC: American Psychiatric Press; 2009. 1–28.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.